Effect of two ergosterol biosynthesis inhibitors on lycopene production by Blakeslea trispora

Process Biochemistry

Volumn 42, Issue 10, 2007, Pages 1460-1464

  Sun, Ying ^a   Yuan, Qi Peng ^a   Vriesekoop, Frank ^b  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

^b UNIVERSITY OF BALLARAT   (Australia)

Author keywords

Blakeslea trispora; Ergosterol; Inhibitor; Ketoconazole; Lycopene; Terbinafine hydrochloride (TH)

Indexed keywords

ALCOHOLS; BIOSYNTHESIS; FERMENTATION; PRODUCTIVITY;

BLAKESLEA TRISPORA; ERGOSTEROL; KETOCONAZOLE; LYCOPENE; TERBINAFINE HYDROCHLORIDE (TH);

PIGMENTS;

BLAKESLEA TRISPORA;

EID: 34548596453     PISSN: 13595113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.procbio.2007.06.006     Document Type: Article

References (18)

1. Rao A.V., and Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic diseases: a review. Nutr Res 19 (1999) 305-323
2. Bramley P.M. Is lycopene beneficial to human health?. Phytochemistry 54 (2000) 233-236
3. López-Nieto M.J., Costa J., Peiro E., Méndez E., Rodríguez-Sáiz M., de la Fuente J.L., et al. Biotechnological lycopene production by mated fermentation of Blakeslea trispora. Appl Microbiol Biotechnol 66 (2004) 153-159
4. Xu F., Yuan Q.P., and Zhu Y. Improved production of lycopene and β-carotene by Blakeslea trispora with oxygen-vectors. Process Biochem 42 (2007) 289-293
5. Parks L.W., and Casey W.M. Physiological implication of sterol biosynthesis in yeast. Annu Rev Microbiol 49 (1995) 95-116
6. Sandmann G. Carotenoid biosynthesis and biotechnological application. Arch Biochem Biophys 385 (2001) 4-12
7. Shimada H., Kondo K., Fraser P.D., Miura Y., and Saito T. Increased carotenoid production by the food yeast Candida utilis through metabolic engineering of the isoprenoid pathway. Appl Environ Microb 7 (1998) 2676-2680
8. Burden R.S., Cooke D.T., and Carter G.A. Inhibitors of sterol biosynthesis and growth in plants and fungi. Phytochemistry 28 (1989) 1791-1804
9. Shear N.H., Villars V.V., and Marsolais C. Terbinafine: an oral and topical antifungal agent. Clin Dermatol 9 (1991) 487-495
10. Borgers M., Van den Bossche H., and De Brabander M. The mechanism of action of the new antimycotic ketoconazole. Am J Med 74 (1983) 2-8
11. Xu F., Yuan Q.P., and Dong H.R. Determination of lycopene and β-carotene by high-performance liquid chromatography using sudan I as internal standard. J Chromatogr B 838 (2006) 44-49
12. Shang F., Wen S.H., Wang X., and Tan T.W. Effect of nitrogen limitation on the ergosterol production by fed-batch culture of Saccharomyces cerevisiae. J Biotechnol 122 (2006) 285-292
13. Xie H.J., Lu Y., Qiu Y.M., Xiao Y., Guo J.Q., Chu M.H., et al. Determination of ergosterol in yeast by HPLC. Process Biotechnol 20 (2000) 75-76
14. Wentzinger L.F., Bach T.J., and Marie-Andrée H. Inhibition of squalene synthase and squalene epoxidase in tobacco cells triggers an up-regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase. Plant Physiol 130 (2002) 334-346
15. Goldstein J.L., and Brown M.S. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
16. Uno J., Shigematsu M.L., and Arai T. Primary site of action of ketoconazole on Candida albicans. Antimicrob Agents Ch 21 (1982) 912-918
17. Sud I.J., and Feingold D.S. Heterogeneity of action mechanisms among antimycotic imidazoles. Antimicrob Agents Ch 8 (1981) 71-74
18. Tamasawa N., Hayakari M., Murakami H., Matsui J., and Suda T. Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver. Atherosclerosis 131 (1997) 237-242